14 January 2026 - Top Stories

Australian healthtech is signalling a shift in ownership and strategy. Potentia Capital has agreed to acquire HotDoc for about A$250 million. The price sits above eight times revenue and at least 30 times EBITDA, reflecting strong demand for data‑driven, consumer‑facing health platforms. Potentia projects 15–20% annual revenue growth for HotDoc over the next five years, building on 2018–2025 growth of 20–25% per year. The deal signals growing private‑equity interest in booking engines and rising competition for traditional GP software ecosystems.

Australian medtech is also pursuing broader global reach. The Medical Technology Association of Australia has joined Austrade’s Trade Diversification Network to help firms enter high‑growth overseas markets, notably Southeast Asia and the Middle East. The collaboration aims to broaden export routes, improve market intelligence and reduce reliance on a small set of buyers. It strengthens MTAA’s MedTech Compass Initiative for scale, regulatory navigation and overseas engagement.

Data security and governance remain a priority. NSW is reworking its surgical mortality review to a framework led by the Clinical Excellence Commission, replacing CHASM with a six‑month transition to mid‑2026 to align with new data sets and cyber standards. Separately, PBS data matching is expanding to verify sponsor and dispensing data against claims, with a December 2025 campaign and ongoing overseas claiming checks to identify overpayments.

Policy and primary care reforms continue to shape funding and collaboration. The Productivity Commission’s final Delivering quality care more efficiently report advocates formal hospital–PHN coordination through collaborative commissioning under the National Health Reform Agreement to lift efficiency and outcomes. In Victoria, Chemist Care Now broadened non‑prescription options to include two hormonal contraceptives and an impetigo treatment, with HRT resupply planned for 2026. The Medicare Mental Health Check In began on 1 January, with public resources and a plan to assess scaling.

Rural care technology and global context feature prominently. A Saskatchewan example shows remote robotic ultrasound guiding examinations from a distant site, combining robotics, live imaging and telehealth to deliver hospital‑level assessments in remote communities. Australia could adopt a similar model, subject to training and interoperability. Internationally, the United States has approved the first oral GLP‑1 weight‑loss tablet (Wegovy), which could reshape pricing and access dynamics and influence Australia’s regulatory pathway.

• Potentia buys HotDoc for ~A$250m; targets 15–20% annual growth.
• MTAA joins Austrade’s Trade Diversification Network to access SEA and Middle East markets.
• NSW shifts to cyber‑aware surgical mortality framework; transition by mid‑2026.
• PBS data matching expands; 36‑month claims campaign and overseas checks.
• Productivity Commission urges formal hospital–PHN collaboration via collaborative commissioning.
• Victoria expands Chemist Care Now; extra OTC options; HRT resupply planned for 2026; Mental Health Check In opened.